MyDx, Inc. (OTCMKTS:MYDX) Launches into California Cannabis Market

823

MyDx, Inc. (OTCMKTS:MYDX) customers in California will now have access to one of the first legally licensed cannabis manufacturing and distribution facilities in San Diego, following a recent announcement from the company.

We haven’t touched upon MYDX in a while here on Street Register, but it’s a company with perhaps one of the most intriguing offerings that operates within the cannabis space without being directly tied to the actual growth, distribution and sale of cannabis.

MyDx, Inc. (OTCMKTS:MYDX)’s flagship product, MyDx®, also known as “My Diagnostic”, is a patented multiuse hand-held chemical analyzer designed to help users test for pesticides in food, chemicals in water, toxins in the air, and the safety and potency of cannabis samples, which is the Company’s initial focus through its CannaDxTM application.

CannaDx users have submitted over 40,000 crowdsourced records revealing the chemical profile of the cannabis they are consuming and how it makes them feel which feeds into the the company’s data analytics platform. This is an invaluable tool for customers and proporietors at every level of the cannabis trade.

This week we have learned that the company has launched its first MyDx360 customers into the California legal cannabis market. In order to provide a complete and seamless product offering for MyDx360 customers, starting with the development of custom oil formulations based on the MyDx Database, as well as supplying the EcoSmartPenTM technology suite to track consumer feedback, MyDx360 customers who have developed proprietary product formulations powered by MyDx are now able to seamlessly transition themselves into full scale legal manufacturing and distribution of cannabis in the State of California through this new partnership.

After months of diligence, MyDx has completed its research into the San Diego legal manufacturing and distribution license holder marketplace. Having reviewed the varying degrees of license approval status that many groups currently hold, MyDx has confirmed the positive approval at both the city and state level of a reputable, legally licensed, manufacturing and distribution partner it has signed an agreement with to support the products developed by MyDx360 customers.

With this complete service, formulated products developed for MyDx360 customers are now able to be fully integrated into the California Cannabis Track-and-Trace (CCTT) system that records the inventory and movement of cannabis products from production to sale.

“MyDx is very excited to now focus on combining what we believe is the most advanced dataset in the industry with our cutting edge scientists and R&D formulators to continue to innovate products for MyDx360 customers working towards maximal impact and satisfaction for their customer base,” stated Daniel Yazbeck, Chief Executive Officer of MyDx. (Source: Globe Newswire)

MyDx isn’t just about the cannabis busniness, however. Its engagement platform os designed to help all manner of buinsesses develop, launch and track the effects of products on consumers to help penetrate their target markets more effectively. As part of the service, companies choose from among MyDx’s many chemical formulations that best align with the physiological response its target demographic is seeking. From there, MyDx can outsource the delivery of those formulations through licensed concentrate manufacturing facilities and provide customer-engagement support via its SAAS (software as a service) platform and MyDx smart devices such as the EcoSmartPen.

We think MYDX has a lot of potential and are going to be interested in continuing to track its activities moving forward. Just stay locked to Street Register for updates, and we’ll deliver important developments on MYDX as they unfold. In the meantime, if you’ve yet to sign up for our 100% free newsletter, do so now! Just enter your active email address into the box below and submit!

Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in MYDX stock, short or long.

 

LEAVE A REPLY